Inhaled chronic obstructive pulmonary disease (COPD) medications prescribed before surgery in patients with early-stage non–small cell lung cancer (NSCLC) were associated with both short- and ...
Please provide your email address to receive an email when new articles are posted on . Less than 40% of the studied veteran cohort were adherent to their inhaled COPD medications. Adherence was found ...
Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...
The analysis included 96 consecutive patients with a diagnosis of COPD and hospitalized in the internal medicine division between August 2022 and April 2023. HealthDay News — Among patients ...
Hosted on MSN
Model carrier microparticles for inhaled medicines developed with high-precision 3D laser printing
They are barely thicker than a human hair—yet they could significantly improve the effectiveness of inhaled medications: carrier particles in dry powder inhalers transport the active ingredient and ...
Short-acting bronchodilators offer quick relief of respiratory symptoms, with effects lasting from 30 minutes to several hours. They are often used as a rescue medication. Long-acting bronchodilators ...
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly ...
Hosted on MSN
Comparing asthma inhalers: How to choose
Asthma inhalers can be for quick relief or long-term control. Rescue inhalers work by relaxing your airway muscles to help you breathe better. People with chronic asthma may need a daily inhaler to ...
MedPage Today on MSN
FDA Approves Generic Flovent Inhaler for Asthma
Move comes 2 years after controversial exit of brand-name product ...
Kenox Pharmaceuticals Inc. (Kenox), a fast‑growing contract development and manufacturing organization (CDMO) dedicated exclusively to Orally Inhaled and Nasal Drug Products (OINDPs) and Ophthalmic ...
Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results